RxDoctor Payments Data

Heather Collison

Physician Assistant · Annapolis, MDNPI 1265770259

Payments from drug & device makers

$3,346in general payments, 2019–2025

Across 157 payments — averaging $21.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$742
  • Sanofi$484
  • AstraZeneca$446
  • Regeneron Healthcare Solutions, Inc.$326
  • Takeda Pharmaceuticals U.S.A., Inc.$244
  • Insmed, Inc.$192
  • plus $910 from 16 others

What the payments were for

  • Food & beverage$3,346100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,346 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$67,771
Medicare patients
218
Services billed
803

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter335$253,045
Dupixent PenDupilumab13$49,092
XolairOmalizumab14$48,861
Breztri AerosphereBudesonide/Glycopyr/Formoterol34$27,635
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr29$15,032
Breo ElliptaFluticasone/Vilanterol24$9,423
Fluticasone-SalmeterolFluticasone Propion/Salmeterol54$5,981
SymbicortBudesonide/Formoterol Fumarate14$4,495
Arnuity ElliptaFluticasone Furoate15$4,014
Albuterol Sulfate HfaAlbuterol Sulfate127$3,456
Montelukast Sodium252$1,982
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$1,767
Ventolin HfaAlbuterol Sulfate15$848
Azithromycin15$225
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$61

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta$742$281,514403 claims
AstraZenecaBreztri Aerosphere, Symbicort$446$32,13048 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →